Can We Use a Biomarker to Guide Antibiotic Treatment in Severe COPD Exacerbations?

Breathe- United Kingdom

doi 10.1183/20734735.0257-2019

Full Text

Abstract

Available in

Date

Authors

Publisher

European Respiratory Society (ERS)

Related search

Shall We Focus on the Eosinophil to Guide Treatment With Systemic Corticosteroids During Acute Exacerbations of COPD?: PRO

Medical Sciences
2018English

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit

PLoS ONE
Multidisciplinary
2015English

Treatment of COPD Exacerbations

Postgraduate Medicine
Medicine
2002English

A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2020English

Eosinophil Count During Severe Acute COPD Exacerbations

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2019French

Validation and Assessment of the COPD Treatment Ratio as a Predictor of Severe Exacerbations

Chronic Obstructive Pulmonary Diseases
PulmonaryRespiratory Medicine
2020English

Neural Respiratory Drive as a Physiological Biomarker to Monitor Change During Acute Exacerbations of COPD

Thorax
PulmonaryRespiratory Medicine
2011English

A Mathematical Model to Guide Antibiotic Treatment Strategies

BMC Medicine
Medicine
2012English

Oxidative Stress and Airway Inflammation in Severe Exacerbations of COPD

Thorax
PulmonaryRespiratory Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy